Verastem to Present at the 2013 ASCO Annual Meeting

Research on the FAK and PI3K/mTOR signaling pathways has revealed critical roles for each in cancer stem cell survival and disease progression.

http://eon.businesswire.com/news/eon/20130523005605/en/Verastem-Present-2013-ASCO-Annual-Meeting